  {"id":46048,"date":"2021-06-15T11:00:18","date_gmt":"2021-06-15T02:00:18","guid":{"rendered":"https:\/\/www.veeva.com\/jp\/?p=46048"},"modified":"2021-06-15T03:14:47","modified_gmt":"2021-06-14T18:14:47","slug":"veeva-development-cloud-streamlining-drug-development-industrywide","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/jp\/news\/veeva-development-cloud-streamlining-drug-development-industrywide\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ Development Cloud\u3067\u696d\u754c\u5168\u4f53\u306e\u533b\u85ac\u54c1\u958b\u767a\u3092\u52b9\u7387\u5316"},"content":{"rendered":"<p style=\"text-align: center;\">\uff5e \u30af\u30ea\u30cb\u30ab\u30eb\u3001\u30ec\u30ae\u30e5\u30e9\u30c8\u30ea\u30fc\u3001\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3001\u304a\u3088\u3073\u5b89\u5168\u6027\u60c5\u5831\u7ba1\u7406\u306e\u305f\u3081\u306e<\/p>\n<p style=\"text-align: center;\">\u7d71\u5408\u5316\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3067\u30b5\u30a4\u30ed\u5316\u3092\u89e3\u6d88\u3057\u3066<\/p>\n<p style=\"text-align: center;\">\u52b9\u7387\u3068\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u5411\u4e0a\u3092\u5b9f\u73fe \uff5e<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\">2021\u5e746\u670815\u65e5<\/p>\n<p style=\"text-align: right;\">³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>\u533b\u85ac\u54c1\u958b\u767a\u306e\u52b9\u7387\u5316\u306b\u5411\u3051\u3066\u696d\u754c\u5168\u4f53\u304c\u30b7\u30d5\u30c8\u3059\u308b\u4e2d\u3001³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306e<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/development-cloud\/\">³Ô¹Ï±¬ÁÏ Development Cloud<\/a><\/strong>\u3092\u5c0e\u5165\u3059\u308b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u304c\u5897\u52a0\u3057\u3066\u3044\u307e\u3059\u3002\u73fe\u5728\u3001650\u793e\u3092\u8d85\u3048\u308b\u4f01\u696d\u304c³Ô¹Ï±¬ÁÏ Development Cloud\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u4f7f\u7528\u3057\u3066\u304a\u308a\u3001\u7570\u306a\u308b\u6a5f\u80fd\u9818\u57df\u306e\u8907\u6570\u306e³Ô¹Ï±¬ÁÏ Vault\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u6d3b\u7528\u3057\u3066\u3001\u533b\u85ac\u54c1\u958b\u767a\u30c1\u30fc\u30e0\u3068\u88fd\u9020\u30c1\u30fc\u30e0\u3068\u306e\u9023\u643a\u5f37\u5316\u3092\u5b9f\u73fe\u3055\u305b\u3066\u3044\u308b\u4f01\u696d\u306f250\u793e\u3092\u8d85\u3048\u3066\u3044\u307e\u3059\u3002 (\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f<strong><a href=\"https:\/\/www.veeva.com\/resources\/veeva-development-cloud-streamlining-drug-development-industrywide\/\">\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n<p>&nbsp;<\/p>\n<p>³Ô¹Ï±¬ÁÏ Development Cloud\u306f\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u3001\u30ec\u30ae\u30e5\u30e9\u30c8\u30ea\u30fc\u3001\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3001\u304a\u3088\u3073\u5b89\u5168\u6027\u60c5\u5831\u7ba1\u7406\u306e\u305f\u3081\u306e\u696d\u52d9\u7528\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30fb\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u7d71\u5408\u5316\u3057\u305f\u30b9\u30a4\u30fc\u30c8\u3067\u3001\u7d44\u7e54\u5185\u306e\u30b5\u30a4\u30ed\u5316\u3092\u89e3\u6d88\u3057\u307e\u3059\u3002\u73fe\u5728\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-clinical\/\">Vault Clinical<\/a><\/strong>\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u3063\u3066\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u8fc5\u901f\u5316\u3055\u305b\u3066\u3044\u308b\u4f01\u696d\u306f350\u793e\u4ee5\u4e0a\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-rim\/\">Vault RIM<\/a><\/strong>\u3067\u30ec\u30ae\u30e5\u30e9\u30c8\u30ea\u30fc\u30d7\u30ed\u30bb\u30b9\u3092\u52b9\u7387\u5316\u3055\u305b\u3066\u3044\u308b\u4f01\u696d\u306f250\u793e\u4ee5\u4e0a\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-quality\/\">Vault Quality<\/a><\/strong>\u3067\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3092\u7d71\u5408\u3057\u3066\u3044\u308b\u4f01\u696d\u306f350\u793e\u4ee5\u4e0a\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-safety\/\">Vault Safety<\/a><\/strong>\u3067\u30d5\u30a1\u30fc\u30de\u30b3\u30d3\u30b8\u30e9\u30f3\u30b9\u3092\u6539\u5584\u3057\u3066\u3044\u308b\u4f01\u696d\u306f35\u793e\u4ee5\u4e0a\u306b\u4e0a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>³Ô¹Ï±¬ÁÏ Development Cloud\u306e<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-platform\/vault-connections\/\">Vault Connections<\/a><\/strong>\u306f\u3001\u6a5f\u80fd\u9818\u57df\u3092\u6a2a\u65ad\u3059\u308b\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u3092\u88fd\u54c1\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u3067\u4fc3\u9032\u3057\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001Vault Connections\u306e\u5c0e\u5165\u4f01\u696d\u306f\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u3068\u30ec\u30ae\u30e5\u30e9\u30c8\u30ea\u30fc\u306e\u7d71\u5408\u306b\u3088\u308b\u7533\u8acb\u306e\u8fc5\u901f\u5316\u3001\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3068\u30ec\u30ae\u30e5\u30e9\u30c8\u30ea\u30fc\u306e\u7d71\u5408\u306b\u3088\u308b\u5909\u66f4\u7ba1\u7406\u3084\u30d0\u30ea\u30a8\u30fc\u30b7\u30e7\u30f3\u7ba1\u7406\u306e\u7c21\u7d20\u5316\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u30c7\u30fc\u30bf\u3068\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u7d71\u5408\u306b\u3088\u308b\u88ab\u9a13\u8005\u767b\u9332\u306e\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306a\u53ef\u8996\u5316\u306a\u3069\u3092\u5b9f\u73fe\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>³Ô¹Ï±¬ÁÏ\u306eVault R&amp;D\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bJim Reilly\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u306f\u3001\u696d\u754c\u306e\u533b\u85ac\u54c1\u958b\u767a\u306e\u8fc5\u901f\u5316\u3092\u652f\u63f4\u3059\u308b\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u5e02\u5834\u306b\u3082\u305f\u3089\u3059\u3053\u3068\u306b\u6ce8\u529b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ Development Cloud\u306b\u3088\u308a\u3001\u304a\u5ba2\u69d8\u306f\u30c1\u30fc\u30e0\u9593\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u6539\u5584\u3057\u3001\u60a3\u8005\u69d8\u3078\u6cbb\u7642\u3092\u8fc5\u901f\u306b\u63d0\u4f9b\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n<p><strong>³Ô¹Ï±¬ÁÏ Development Cloud<\/strong><strong>\u306b\u95a2\u3059\u308b\u304a\u5ba2\u69d8\u306e\u30b3\u30e1\u30f3\u30c8\uff1a<\/strong><\/p>\n<p>argenx\u793e\u306e\u696d\u52d9\u60c5\u5831\u30b7\u30b9\u30c6\u30e0\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bKlaas Boone\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u73fe\u5728\u306f\u30b9\u30d4\u30fc\u30c9\u3068\u52b9\u7387\u304c\u6c42\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u3082\u306f\u3084\u8907\u6570\u306e\u30b5\u30a4\u30ed\u5316\u3057\u305f\u30b7\u30b9\u30c6\u30e0\u306b\u307e\u305f\u304c\u3063\u3066\u884c\u3046\u533b\u85ac\u54c1\u958b\u767a\u306e\u7ba1\u7406\u306f\u6301\u7d9a\u53ef\u80fd\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u5f53\u793e\u306f\u696d\u52d9\u6539\u5584\u306b\u975e\u5e38\u306b\u7a4d\u6975\u7684\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ Development Cloud\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u3063\u3066\u30c1\u30fc\u30e0\u3092\u9023\u643a\u3055\u305b\u308b\u3053\u3068\u3067\u3001\u81e8\u5e8a\u8a66\u9a13\u304b\u3089\u85ac\u4e8b\u7533\u8acb\u3001\u88fd\u9020\u307e\u3067\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u63a8\u9032\u306b\u5f79\u7acb\u3064\u3068\u8003\u3048\u307e\u3059\u3002\u300d<\/p>\n<p>Cerevel Therapeutics\u793e\u306e\u85ac\u4e8b\u696d\u52d9\u62c5\u5f53\u30b0\u30ed\u30fc\u30d0\u30eb\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bDee DeOliveira\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u30af\u30ea\u30cb\u30ab\u30eb\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3068\u85ac\u4e8b\u7533\u8acb\u3092\u7d71\u5408\u5316\u3059\u308b\u3053\u3068\u3067\u3001\u30d7\u30ed\u30c8\u30b3\u30eb\u3001\u6cbb\u9a13\u85ac\u6982\u8981\u3001\u305d\u306e\u4ed6\u306e\u4e3b\u8981\u8a66\u9a13\u6587\u66f8\u304c\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u3067\u5165\u624b\u53ef\u80fd\u306b\u306a\u308a\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u78ba\u4fdd\u3092\u5b9f\u73fe\u3057\u3066\u3044\u307e\u3059\u3002Vault Connections\u306e\u5c0e\u5165\u306b\u3088\u308a\u3001\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u304c\u53ef\u80fd\u306b\u306a\u3063\u305f\u3053\u3068\u306b\u5927\u304d\u306a\u671f\u5f85\u304c\u5bc4\u305b\u3089\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u3053\u308c\u306f\u533b\u85ac\u54c1\u958b\u767a\u306e\u8fc5\u901f\u5316\u306b\u5411\u3051\u305f\u62e1\u5f35\u3084\u81ea\u52d5\u5316\u304c\u53ef\u80fd\u306a\u30d7\u30ed\u30bb\u30b9\u306e\u307b\u3093\u306e\u59cb\u307e\u308a\u306b\u3059\u304e\u307e\u305b\u3093\u3002\u300d<\/p>\n<p>Spark Therapeutics\u793e\u306eIT ³Ô¹Ï±¬ÁÏ\u30bb\u30f3\u30bf\u30fc\u30fb\u30aa\u30d6\u30fb\u30a8\u30af\u30bb\u30ec\u30f3\u30b9\u306e\u30ea\u30fc\u30c0\u30fc\u3067\u3042\u308bJim Clark\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u5f53\u793e\u3067\u306f\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u696d\u52d9\u3068\u30ec\u30ae\u30e5\u30e9\u30c8\u30ea\u30fc\u696d\u52d9\u3092\u7d71\u5408\u5316\u3057\u3066\u30c1\u30fc\u30e0\u9593\u306e\u60c5\u5831\u5171\u6709\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u30af\u30e9\u30a6\u30c9\u4e0a\u3067\u3059\u3079\u3066\u7e4b\u304c\u3063\u3066\u3044\u308b³Ô¹Ï±¬ÁÏ Vault\u30b9\u30a4\u30fc\u30c8\u306e\u5c0e\u5165\u306f\u3001\u7d99\u7d9a\u7684\u306b\u533b\u85ac\u54c1\u958b\u767a\u3092\u6210\u529f\u3055\u305b\u308b\u305f\u3081\u306b\u6975\u3081\u3066\u91cd\u8981\u3067\u3059\u3002\u300d<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010<\/strong><strong>³Ô¹Ï±¬ÁÏ Systems<\/strong><strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong><br \/>\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u30011,000\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30d1\u30d6\u30ea\u30c3\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3\u4f01\u696d\u3068\u3057\u3066³Ô¹Ï±¬ÁÏ\u306f\u3001\u9867\u5ba2\u3084\u5f93\u696d\u54e1\u3001\u63d0\u643a\u4f01\u696d\u3001\u682a\u4e3b\u3001\u30b5\u30fc\u30d3\u30b9\u63d0\u4f9b\u696d\u754c\u3092\u542b\u3080\u3059\u3079\u3066\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u5229\u76ca\u30d0\u30e9\u30f3\u30b9\u3092\u4fdd\u3064\u3053\u3068\u306b\u30b3\u30df\u30c3\u30c8\u3057\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<a href=\"https:\/\/veeva.com\/jp\/\">https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>\u3010Forward-looking Statements\u3011<br \/>\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended January 31, 2021.This is available on the company\u2019s website at <a href=\"http:\/\/veeva.com\/\">veeva.com<\/a> under the Investors section and on the SEC\u2019s website at <a href=\"http:\/\/sec.gov\/\">sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>650\u793e\u4ee5\u4e0a\u306e\u4f01\u696d\u304c³Ô¹Ï±¬ÁÏ Development Cloud\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u4f7f\u7528\u3057\u3066\u304a\u308a\u3001\u7570\u306a\u308b\u6a5f\u80fd\u9818\u57df\u306e\u8907\u6570\u306e³Ô¹Ï±¬ÁÏ Vault\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u6d3b\u7528\u3057\u3066\u3001\u30c1\u30fc\u30e0\u9593\u306e\u306e\u9023\u643a\u5f37\u5316\u3092\u5b9f\u73fe\u3055\u305b\u3066\u3044\u308b\u4f01\u696d\u306f250\u793e\u4ee5\u4e0a\u3067\u3059\u3002<\/p>\n","protected":false},"author":131,"featured_media":46033,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-46048","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/46048"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=46048"}],"version-history":[{"count":3,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/46048\/revisions"}],"predecessor-version":[{"id":46052,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/46048\/revisions\/46052"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media\/46033"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=46048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=46048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=46048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}